Here’s whether Abbott Laboratories (ABT) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bearish.
🔴
Bearish
Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-1.37% over 10 days); weak 1-year return of -25.4%; 3-month momentum negative (-20.5%). Currently 30.4% off its 52-week high. Score: -6/7.
ABT is trading below its 200-day MA ($122.59) — a key warning sign the longer-term trend is under pressure. An RSI of 30.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -25.4% compares to +35.1% for SPY (trailed the market by 60.5%). The current 30.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $7,464 today
vs. S&P 500 (SPY) — same period trailed market by 60.5%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($122.59)
✗Above 50-day MA ($107.99)
✓RSI(14) neutral zone (30–70) — currently 30.5
✗Positive return (-25.4%)
!Within 10% of period high (−30.4%)
Period Range $96.81
$93.92$139.06
RSI (14) 30.5
0 · OversoldOverbought · 100
Key Metrics
Price$96.81
Period Return-25.4%
Period High$139.06
Period Low$93.92
Drawdown−30.4%
MA-50$107.99
MA-200$122.59
RSI (14)30.5
Avg Volume (30d)12.9M
vs. SPYtrailed by 60.5%
Return Rank#848 of 996
Trend Signals
Price is below the 200-day moving average ($122.59)
Price is below the 50-day moving average ($107.99)